An open label, balanced, randomized, two-treatment, two-period, two-sequence, single oral dose, crossover, bioequivalence study of trimetazidine dihydrochloride extended release capsules 80 mg (Trade Name FLAVEDON OD) OF SERDIA PHARMACEUTICALS PVT. LTD., INDIA comparing with Vastarel® OD 80 MG prolonged release hard capsule (TRADE NAME VASTAREL® OD 80 MG) OF EGIS PHARMACEUTICALS PLC, Hungary, in normal, healthy, adult, human male subjects under fasting condition.
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Trimetazidine (Primary)
- Indications Angina pectoris; Eye disorders; Ischaemic heart disorders; Tinnitus
- Focus Pharmacokinetics
- Sponsors Serdia Pharmaceuticals
- 18 Jun 2020 New trial record